Fig. 2 | British Journal of Cancer

Fig. 2

From: SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment

Fig. 2

Clinical outcome of SHON protein nuclear expression in breast cancer. Kaplan–Meier plots of the rates of breast cancer specific survival (BCSS; months) in the NUH-ES-BC cohort (n = 1,650) according to SHON protein nuclear expression (SHON-Nuc) status. The p value from the log rank test is shown in each panel; ‘n' is the number of samples in each group. High risk, NPI scores ≥ 3.4; ERα, oestrogen receptor α; +, positive expression; −, negative expression

Back to article page